Trial intelligence / Profile preview

Pitolisant for Alcohol Use Disorder (Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial)

2016-000207-90Phase 2Terminated

Sponsor
Biprojet
Start
Jul 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in alcohol use disorder (AUD) comparing Pitolisant with Placebo (2 arms). Primary endpoint: Decrease in monthly heavy drinking days. Started Jul 2016; status: terminated.

02

Drugs

pitolisant
03

Conditions

alcohol use disorder (AUD)

Beyond the preview

Go deeper on 2016-000207-90.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2016-000207-90.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call